LEMAITRE VASCULAR, INC. Cost of Revenue
LEMAITRE VASCULAR, INC. (LMAT) reported Cost of Revenue of $19.62 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-05
- LEMAITRE VASCULAR, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $19.62M, a 1.87% increase year-over-year.
- LEMAITRE VASCULAR, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $18.16M, a 1.60% decline year-over-year.
- LEMAITRE VASCULAR, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $18.26M, a 6.63% increase year-over-year.
- LEMAITRE VASCULAR, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $15.09M, a 14.45% decline year-over-year.
- LEMAITRE VASCULAR, INC. cost of goods and services sold for fiscal 2025 was $71.06M, a 3.05% increase from fiscal 2024.
- LEMAITRE VASCULAR, INC. cost of goods and services sold for fiscal 2024 was $68.96M, a 3.80% increase from fiscal 2023.
- LEMAITRE VASCULAR, INC. cost of goods and services sold for fiscal 2023 was $66.44M, a 17.06% increase from fiscal 2022.
- LEMAITRE VASCULAR, INC. cost of goods and services sold for fiscal 2022 was $56.76M, a 7.00% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.62M 10-Q · filed 2026-08-05 | $37.77M 10-Q · filed 2026-08-05 | $56.04M derived: sum of 3 quarters · filed 2026-08-05 | $71.13M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $18.16M 10-Q · filed 2026-05-06 | $36.42M derived: sum of 2 quarters · filed 2026-05-06 | $51.51M derived: sum of 3 quarters · filed 2026-05-06 | $70.77M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $18.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $33.35M derived: sum of 2 quarters · filed 2026-02-26 | $52.61M derived: sum of 3 quarters · filed 2026-08-05 | $71.06M 10-K · filed 2026-02-26 |
| 2025-09-30 | $15.09M 10-Q · filed 2025-11-07 | $34.35M derived: sum of 2 quarters · filed 2026-08-05 | $52.80M 10-Q · filed 2025-11-07 | $69.93M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $19.26M 10-Q · filed 2026-08-05 | $37.71M 10-Q · filed 2026-08-05 | $54.84M derived: sum of 3 quarters · filed 2026-08-05 | $72.48M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $18.45M 10-Q · filed 2026-05-06 | $35.58M derived: sum of 2 quarters · filed 2026-05-06 | $53.22M derived: sum of 3 quarters · filed 2026-05-06 | $70.60M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $17.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $34.77M derived: sum of 2 quarters · filed 2026-02-26 | $52.15M derived: sum of 3 quarters · filed 2026-02-26 | $68.96M 10-K · filed 2026-02-26 |
| 2024-09-30 | $17.64M 10-Q · filed 2025-11-07 | $35.02M derived: sum of 2 quarters · filed 2025-11-07 | $51.84M 10-Q · filed 2025-11-07 | $67.45M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $17.38M 10-Q · filed 2025-08-06 | $34.19M 10-Q · filed 2025-08-06 | $49.81M derived: sum of 3 quarters · filed 2026-02-26 | $66.41M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $16.81M 10-Q · filed 2025-05-08 | $32.43M derived: sum of 2 quarters · filed 2026-02-26 | $49.03M derived: sum of 3 quarters · filed 2026-02-26 | $67.06M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $15.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $32.21M derived: sum of 2 quarters · filed 2026-02-26 | $50.24M derived: sum of 3 quarters · filed 2026-02-26 | $66.44M 10-K · filed 2026-02-26 |
| 2023-09-30 | $16.60M 10-Q · filed 2024-11-08 | $34.63M derived: sum of 2 quarters · filed 2024-11-08 | $50.82M 10-Q · filed 2024-11-08 | $65.72M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $18.03M 10-Q · filed 2024-08-08 | $34.22M 10-Q · filed 2024-08-08 | $49.12M derived: sum of 3 quarters · filed 2025-02-28 | $63.08M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $16.19M 10-Q · filed 2024-05-10 | $31.09M derived: sum of 2 quarters · filed 2025-02-28 | $45.05M derived: sum of 3 quarters · filed 2025-02-28 | $59.35M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $14.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $28.86M derived: sum of 2 quarters · filed 2025-02-28 | $43.16M derived: sum of 3 quarters · filed 2025-02-28 | $56.76M 10-K · filed 2025-02-28 |
| 2022-09-30 | $13.96M 10-Q · filed 2023-11-07 | $28.26M derived: sum of 2 quarters · filed 2023-11-07 | $41.85M 10-Q · filed 2023-11-07 | $55.40M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $14.30M 10-Q · filed 2023-08-08 | $27.90M 10-Q · filed 2023-08-08 | $41.44M derived: sum of 3 quarters · filed 2024-02-29 | $54.95M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $13.60M 10-Q · filed 2023-05-09 | $27.15M derived: sum of 2 quarters · filed 2024-02-29 | $40.65M derived: sum of 3 quarters · filed 2024-02-29 | $54.56M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $13.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $27.05M derived: sum of 2 quarters · filed 2024-02-29 | $40.96M derived: sum of 3 quarters · filed 2024-02-29 | $53.04M 10-K · filed 2024-02-29 |
| 2021-09-30 | $13.50M 10-Q · filed 2022-11-08 | $27.41M derived: sum of 2 quarters · filed 2022-11-08 | $39.49M 10-Q · filed 2022-11-08 | $52.64M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $13.91M 10-Q · filed 2022-08-05 | $25.99M 10-Q · filed 2022-08-05 | $39.14M derived: sum of 3 quarters · filed 2023-03-01 | $52.85M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $12.08M 10-Q · filed 2022-05-10 | $25.23M derived: sum of 2 quarters · filed 2023-03-01 | $38.94M derived: sum of 3 quarters · filed 2023-03-01 | $46.76M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $13.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $26.86M derived: sum of 2 quarters · filed 2023-03-01 | $34.68M derived: sum of 3 quarters · filed 2023-03-01 | $44.75M 10-K · filed 2023-03-01 |
| 2020-09-30 | $13.71M 10-Q · filed 2021-11-04 | $21.53M derived: sum of 2 quarters · filed 2021-11-04 | $31.60M 10-Q · filed 2021-11-04 | $41.86M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $7.82M 10-Q · filed 2021-08-05 | $17.89M 10-Q · filed 2021-08-05 | $28.15M derived: sum of 3 quarters · filed 2022-02-28 | $37.09M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $10.07M 10-Q · filed 2021-05-10 | $20.33M derived: sum of 2 quarters · filed 2022-02-28 | $29.26M derived: sum of 3 quarters · filed 2022-02-28 | $38.43M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $10.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $19.20M derived: sum of 2 quarters · filed 2022-02-28 | $28.36M derived: sum of 3 quarters · filed 2022-02-28 | $37.38M 10-K · filed 2022-02-28 |
| 2019-09-30 | $8.93M 10-Q · filed 2020-11-06 | $18.10M derived: sum of 2 quarters · filed 2020-11-06 | $27.12M 10-Q · filed 2020-11-06 | $36.29M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $9.17M 10-Q · filed 2020-08-06 | $18.18M 10-Q · filed 2020-08-06 | $27.35M derived: sum of 3 quarters · filed 2021-03-12 | $34.26M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | $9.02M 10-Q · filed 2020-05-08 | $18.19M derived: sum of 2 quarters · filed 2021-03-12 | $25.10M derived: sum of 3 quarters · filed 2021-03-12 | $33.12M derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $9.17M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $16.08M derived: sum of 2 quarters · filed 2021-03-12 | $24.11M derived: sum of 3 quarters · filed 2021-03-12 | $31.63M 10-K · filed 2021-03-12 |
| 2018-09-30 | $6.91M 10-Q · filed 2019-11-08 | $14.94M derived: sum of 2 quarters · filed 2019-11-08 | $22.46M 10-Q · filed 2019-11-08 | $30.36M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $8.03M 10-Q · filed 2018-08-06 | $15.55M 10-Q · filed 2019-08-06 | $23.45M derived: sum of 3 quarters · filed 2020-03-12 | $30.69M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $7.52M 10-Q · filed 2019-05-06 | $15.42M derived: sum of 2 quarters · filed 2020-03-12 | $22.67M derived: sum of 3 quarters · filed 2020-03-12 | $30.90M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $7.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $15.15M derived: sum of 2 quarters · filed 2020-03-12 | $23.38M derived: sum of 3 quarters · filed 2020-03-12 | $30.17M 10-K · filed 2020-03-12 |
| 2017-09-30 | $7.25M 10-Q · filed 2018-11-02 | $15.48M derived: sum of 2 quarters · filed 2018-11-02 | $22.27M 10-Q · filed 2018-11-02 | |
| 2017-06-30 | $8.24M 10-Q · filed 2018-08-06 | $15.02M 10-Q · filed 2018-08-06 | ||
| 2016-12-31 | $26.21M 10-K · filed 2019-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |